Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F Little

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Blood|December 17, 2016
Measure for measure: minimal residual disease in CLLRichard F Little, Lisa M McShane
The Journal of Infectious Diseases|May 22, 2019
Are There Clues to Oral Kaposi Sarcoma-Associated Herpesvirus Shedding and Kaposi Sarcoma Oncogenesis in the Oral Microbiome?Richard F Little, Thomas S Uldrick
Current Infectious Disease Reports|March 19, 2003
Update on the Pathogenesis, Diagnosis, and Therapy of AIDS-related LymphomaRichard F. Little, Wyndham H. Wilson
Nature Clinical Practice. Oncology|September 1, 2005
Therapy insight: AIDS-related malignancies--the influence of antiviral therapy on pathogenesis and managementRobert Yarchoan, Giovanna Tosato, Richard F Little
Current Infectious Disease Reports|January 15, 2003
Update on Kaposi's Sarcoma: A Gammaherpesvirus- induced MalignancyPallavi P. Kumar, Richard F. Little, Robert Yarchoan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Including persons with HIV infection in cancer clinical trialsGovind C Persad, Richard F Little, Christine Grady
Hematology/Oncology Clinics of North America|November 28, 2016
Update on Burkitt LymphomaKieron Dunleavy, Richard F Little, Wyndham H Wilson
Journal of the National Cancer Institute|August 20, 2015
Design Issues in Randomized Clinical Trials of Maintenance TherapiesBoris Freidlin, Richard F Little, Edward L Korn
JAMA Oncology|May 12, 2017
Myeloma Minimal Residual Disease and SurrogacyRichard F Little, Lisa M McShane, Boris Freidlin
Cancer|April 23, 2008
Reversible features of cervical cancer in human immunodeficiency virus infection: impaired access, impaired surveillance, impaired immunity, impaired outcomesRichard F Little, Andrea M Denicoff, Edward L Trimble
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Blood|December 17, 2016
Measure for measure: minimal residual disease in CLLRichard F Little, Lisa M McShane
The Journal of Infectious Diseases|May 22, 2019
Are There Clues to Oral Kaposi Sarcoma-Associated Herpesvirus Shedding and Kaposi Sarcoma Oncogenesis in the Oral Microbiome?Richard F Little, Thomas S Uldrick
Current Infectious Disease Reports|March 19, 2003
Update on the Pathogenesis, Diagnosis, and Therapy of AIDS-related LymphomaRichard F. Little, Wyndham H. Wilson
Nature Clinical Practice. Oncology|September 1, 2005
Therapy insight: AIDS-related malignancies--the influence of antiviral therapy on pathogenesis and managementRobert Yarchoan, Giovanna Tosato, Richard F Little
Current Infectious Disease Reports|January 15, 2003
Update on Kaposi's Sarcoma: A Gammaherpesvirus- induced MalignancyPallavi P. Kumar, Richard F. Little, Robert Yarchoan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Including persons with HIV infection in cancer clinical trialsGovind C Persad, Richard F Little, Christine Grady
Hematology/Oncology Clinics of North America|November 28, 2016
Update on Burkitt LymphomaKieron Dunleavy, Richard F Little, Wyndham H Wilson
Journal of the National Cancer Institute|August 20, 2015
Design Issues in Randomized Clinical Trials of Maintenance TherapiesBoris Freidlin, Richard F Little, Edward L Korn
JAMA Oncology|May 12, 2017
Myeloma Minimal Residual Disease and SurrogacyRichard F Little, Lisa M McShane, Boris Freidlin
Cancer|April 23, 2008
Reversible features of cervical cancer in human immunodeficiency virus infection: impaired access, impaired surveillance, impaired immunity, impaired outcomesRichard F Little, Andrea M Denicoff, Edward L Trimble
Pageof 13